2000
DOI: 10.1016/s0040-4039(00)01760-3
|View full text |Cite
|
Sign up to set email alerts
|

A convergent synthesis of the renin inhibitor CGP60536B

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
42
0

Year Published

2003
2003
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(42 citation statements)
references
References 8 publications
0
42
0
Order By: Relevance
“…The diastereoselective α‐alkylation of amide 18 , which was prepared from commercially available hex‐5‐ynoic acid ( 17 ), afforded the tertiary stereogenic center at C14 of the cladiellins 18. The superiority of pseudoephenamine as an auxiliary in asymmetric alkylation reactions involving isopropyl iodide as the electrophile allowed 19 to be prepared on a multigram scale 19. Successive hydrolysis and amide coupling reactions yielded a Weinreb amide, which was subsequently allowed to react with an acetylenyl Grignard reagent to give ketone 21 .…”
Section: Methodsmentioning
confidence: 99%
“…The diastereoselective α‐alkylation of amide 18 , which was prepared from commercially available hex‐5‐ynoic acid ( 17 ), afforded the tertiary stereogenic center at C14 of the cladiellins 18. The superiority of pseudoephenamine as an auxiliary in asymmetric alkylation reactions involving isopropyl iodide as the electrophile allowed 19 to be prepared on a multigram scale 19. Successive hydrolysis and amide coupling reactions yielded a Weinreb amide, which was subsequently allowed to react with an acetylenyl Grignard reagent to give ketone 21 .…”
Section: Methodsmentioning
confidence: 99%
“…In work on peptide isosteres, the 1,6-dioxa-4azaspiro [4.4]nonane 45 was prepared (Scheme 11). 23 The substrate 43 can be prepared from (+)-pseudoephedrine isovaleramide. Treatment of 43 with NBS in DME-H 2 O provides the amide acetal 44 with a single configuration at the spirocenter and as a 6:1 mixture of trans/cis ring substituents.…”
Section: 6-dioxa-4-azaspiro[44]nonanementioning
confidence: 99%
“…157,158 A number of synthetic approaches [159][160][161][162] to aliskiren have been patented [163][164][165][166][167] by Novartis and Speedel Pharma (Basel, Switzerland) or published in a number of original articles. [168][169][170][171][172][173] Synthetic strategies 174 are often based on visual imaging of a target structure. 175 For several aliskiren syntheses, a highly enantioselective hydrogenation of a selected substrate has been chosen to insert a chiral center.…”
Section: Rh-catalyzed Hydrogenation To Drug and Natural Product Synthmentioning
confidence: 99%